Guggenheim Raises Elevance Health Price Target to $460
Guggenheim increased its price target for Elevance Health to $460 per share from $455, according to ratings data from Benzinga.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Guggenheim lifted its price target for Elevance Health to $460 per share from the previous $455. Dow Jones Newswires cited ratings information published by Benzinga.
The action concerns the analyst assessment of Elevance Health shares.
why it matters
For markets, the item signals a revised valuation view on Elevance Health from Guggenheim; no further rating or rationale details were provided.
instruments
sources
- Elevance Health Price Target Raised to $460.00/Share From $455.00 by Guggenheim — Dow Jones Newswires, 12 October 2026 at 13:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗